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Abstract: Previously, the abundance of p42/44 and p38 MAPK proteins had been shown to be
higher in arteries of 1- to 2-week-old compared to 2- to 3-month-old rats. However, the role of
MAPKs in vascular tone regulation in early ontogenesis remains largely unexplored. We tested
the hypothesis that the contribution of p42/44 and p38 MAPKs to the contraction of peripheral
arteries is higher in the early postnatal period compared to adulthood. Saphenous arteries of 1- to
2-week-old and 2- to 3-month-old rats were studied using wire myography and western blotting. The
α1-adrenoceptor agonist methoxamine did not increase the phosphorylation level of p38 MAPK in
either 1- to 2-week-old or 2- to 3-month-old rats. Accordingly, inhibition of p38 MAPK did not affect
arterial contraction to methoxamine in either age group. Methoxamine increased the phosphorylation
level of p42/44 MAPKs in arteries of 2- to 3-month-old and of p44 MAPK in 1- to 2-week-old rats.
Inhibition of p42/44 MAPKs reduced methoxamine-induced contractions in arteries of 2- to 3-month-
old, but not 1- to 2-week-old rats. Thus, despite a high abundance in arterial tissue, p38 and m do not
regulate contraction of the saphenous artery in the early postnatal period. However, p42/44 MAPK
activity contributes to arterial contractions in adult rats.
Keywords: p38 MAPK; p42/44 MAPK; ERK1/; early postnatal ontogenesis; smooth muscle;
functional remodeling
1. Introduction
Early postnatal maturation is associated with growth and development of different
organs and systems, including the circulatory system. The development of the vascu-
lar system is a complex process and occurs at different structural and functional levels,
from the systemic (maturation is accompanied by an increase in blood pressure [1,2])
to the molecular (maturational changes in protein expression and of the mechanisms of
vascular smooth muscle contractility control [3–6]). Functional remodeling of vascular
smooth muscle during postnatal development includes (but is not limited to) an increase
in the Ca2+-dependent control of contractility and a decrease in the Ca2+-sensitivity of the
contractile apparatus [3].
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MAPKs were shown to regulate the Ca2+-sensitivity of vascular smooth muscle con-
traction, due to augmenting MLCK activity [7] and also due to a PKC-dependent weakening
of the inhibitory effect of caldesmon [8,9]. Therefore, both p38 and p42/44 MAPKs increase
smooth muscle cell contractility in response to a variety of stimuli [8,10–17]. In particular,
the contribution of p42/44 and p38 MAPKs to vascular contraction to the α1-adrenoceptor
agonist phenylephrine has been shown previously in the abdominal aorta of adult rats [17].
Of note, α1-adrenoceptors are very important for the regulation of vascular tone, espe-
cially in small resistance arteries, where they mediate the vasoconstrictor influence of
sympathetic nerves. In addition, MAPKs activation, detected by their site-specific phospho-
rylation, may differ in time dynamics from the vasocontractile response, which suggests
their participation in other parallel processes, besides smooth muscle contraction [18].
Our previous study has revealed that the abundance of p42/44 and p38 MAPK
proteins is considerably higher in muscular type saphenous arteries of 1- to 2-week-old
rats in comparison to adult ones [3]. Similarly, in elastic type arteries (ovine carotid artery),
p42/44 MAPKs were shown to be more abundant in near-term fetuses in comparison to
adult ewes [19]. Further, more pronounced effects of p42/44 MAPK inhibitors on contractile
responses have been shown in ovine carotid artery of fetuses compared to adult ewes [19],
suggesting a role of MAPKs in the remodeling of contractility mechanisms during the
early postnatal period. Indeed, activation of α1-adrenoceptors led to phosphorylation of
p42/44 MAPKs in cerebral arteries of fetal ewes, but not in those of adult ewes [20,21].
All these data point to a greater functional role of p42/44 MAPKs in the regulation of
contraction, at least in relatively large elastic type arteries in early ontogenesis. However,
the role of MAPKs, particularly p38, in the regulation of contraction in immature small
muscular type arteries from peripheral circulation is relatively unexplored. Thus, we
tested the hypothesis that the contribution of p42/44 and p38 MAPKs to α1-adrenergic
contraction of peripheral muscular type arteries is higher in rats during the early postnatal
period, compared to adults.
2. Results
First, we compared the protein content of p38 and p42/44 MAPKs in saphenous
arteries of 1- to 2-week-old and 2- to 3-month-old rats. As before [3], the content of p38 and
p42/44 MAPKs was considerably higher in arteries of 1- to 2-week-old rats in comparison
to 2- to 3-month-old rats (Figure 1a–c).
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Figure 1. p38, p42 and p44 MAPK protein abundance is higher in saphenous arteries of 1- to 2-week-
old rats. Protein abundance of MAPK p38 (a), n = 4, p42 (b), n = 4 and p44 (c), n = 4 in saphenous
arteries of 2- to 3-month-old and 1- to 2-week-old rats. * p < 0.05 (unpaired Student t-test).
Further, we evaluated whether p38 and p42/44 MAPKs are activated during α1-
adrenoceptor stimulation in saphenous arteries of 2- to 3-month-old and 1- to 2-week-old
rats by measuring their phosphorylation level upon activation by a submaximal concen-
tration of the α1-adrenoceptor agonist methoxamine (MX, up to 10 µM, see Methods).
In addition, the effects of MAPK inhibitors on arterial contractile responses to MX were
also studied.
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We did not detect differences in the phosphorylation level of p38 MAPK before
and during MX-induced stimulation in arteries of either 2- to 3-month-old (Figure 2a) or
1- to 2-week-old (Figure 2b) rats. Moreover, we did not observe effects of two different
p38 MAPK inhibitors, SB202190 [22] and SB220025 [23] on the contractile response to MX in
arteries of both age groups (Figure 2c,d). Therefore, despite a higher content of p38 MAPK
in arteries of 1- to 2-week-old rats, the data suggest that it does not regulate their contractile
responses to MX.
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Figure 2. p38 MAPK does not contribute to contractile responses of rat saphenous arteries to MX.
(a,b). Phosphorylation level of p38 MAPK in arteries of 2- to 3-month-old ((a), n = 3 for non-activated
and n = 4 for activated vessels) and 1- to 2-week-old ((b), n = 4 for non-activated and n = 4 for
activated vessels) rats. (c,d). Concentration-response relationships to MX in the presence of 1 µM
SB202190, 1 µM SB220025 or DMSO (vehicle of the inhibitors) of arteries from 2- to 3-month-old
(c) and 1- to 2-week-old (d) rats. Numbers in parenthesis indicate the number of animals.
Further, we compared phosphorylation levels of p42/44 MAPKs before and during
the MX-induced stimulation of arteries of 2- to 3-month-old and 1- to 2-week-old rats and
the effects of a p42/44 MAPK inhibitor on MX-induced contractile responses (Figure 3a–d).
The phosphorylation level of p42 MAPK increased after MX-induced stimulation in ar-
teries of 2- to 3-month-old rats; this was not observed in arteries of 1- to 2-week-old rats.
The phosphorylation level of p44 MAPK after MX-induced stimulation increased slightly
(approximately 1.5 times, Figure 3d) in arteries of 1- to 2-week-old rats, and was consid-
erably augmented in arteries of 2- to 3-month-old rats (approximately 3 times, Figure 3c).
The higher degree of p42/44 MAPK activation in arteries of 2- to 3-month-old animals
correlated well with the effects of the p42/44 MAPK inhibitor U0126 [22]. In comparison
to its inactive analogue U0124, U0126 decreased contractile response to MX in arteries of 2-
to 3-month-old animals (Figure 3e); this was not observed in arteries of 1- to 2-week-old
rats (Figure 3f). These data show that p42/44 MAPKs are important for fully manifested
contractions of arteries in 2- to 3-month-old rats, but not in those 1- to 2-weeks old.
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Figure 3. p42/44 MAPKs regulate contractile responses of saphenous arteries in 2- to 3-month-old,
but not 1- to 2-week-old rats. (a,b). Phosphorylation level of p42 MAPK in arteries of 2- to 3-month-
old ((a), n = 4 for non-activated and n = 4 for activated vessels) and 1- to 2-week-old ((b), n = 4 for
non-activated and n = 4 for activated vessels) rats. (c,d). Phosphorylation level of p44 MAPK in
arteries of 2- to 3-month-old ((c), n = 4 for non-activated and n = 4 for activated vessels) and 1- to
2-week-old ((d), n = 4 for non-activated and n = 4 for activated vessels) rats. (e,f). Concentration-
response relationships to MX in the presence of 10 µM U0126 or 10 µM U0124 of arteries from 2- to
3-month-old (e) and 1- to 2-week-old (f) rats. * p < 0.05 (unpaired Student t-test), # p < 0.05 (R peated
Measures ANOVA). Numbers in parenthe is indicate the number of animals.
3. Discussion
3.1. p38 MAPK Does Not Regulate α1-Adrenergic Contractions of Saphenous Arteries at Both Ages
Two sets of our results show that p38 MAPK does not regulate α1-adrenoceptor-
mediated contractions of the muscular type saphenous artery of either adult or 1- to
2-week-old rats. First, we did not observe an increase in the p38 phosphorylation level
in response to MX in any age group, i.e., p38 MAPK is not activated upon α1-adrenergic
stimulation in arteries of both age groups.
Second, we studied the effects of two structurally different p38 MAPK inhibitors,
SB202190 and SB220025 [22,23], on arterial contractile responses in two age groups. The
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concentration of the p38 MAPK inhibitors used was selected based on our results of a
separate experimental series involving a higher concentration of SB202190. In parallel,
SB202474, an inactive analogue of SB202190, was used as a control for non-specific effects
of the inhibitor. In saphenous arteries of 1- to 2-week-old rats, both SB202190 (10 µM)
and SB202474 considerably reduced contractile responses to MX compared to vehicle-
treated preparations (Figure S1). Thus, higher concentrations of the p38 MAPK inhibitor
cannot be used, since they show non-specific effects, at least in the immature vasculature
of younger rats. Therefore, an inhibitor concentration of 1 µM was chosen for the main
experimental series. In this concentration, both SB202190 and SB220025 had no effect on
arterial contractile responses of either 2- to 3-month-old or 1- to 2-week-old rats.
Notably, a contribution of p38 MAPK to α1-adrenergic contraction of the aorta was
previously described for adult rats [17]. In addition, p38 MAPK was shown to participate
in the norepinephrine-induced actin polymerization and contraction of rat small mesenteric
arteries [15]. Moreover, in several other studies p38 MAPK was shown to regulate the
contraction of rat aorta to AngII [24], ET-1 [8,11] and serotonin [8], the contraction of rat
common carotid arteries to serotonin [12], as well as pressure-induced contraction of rat
skeletal muscle arterioles [25]. However, some studies do not support the idea of p38
MAPK participation in the control of adrenergic contractions of arteries. For example,
no role of p38 MAPK was found in the contraction of the aorta to phenylephrine [24] or
skeletal muscle arterioles to norepinephrine [25]. Altogether these data point to a vascular
bed- and agonist-specific activation of p38 MAPK and, consequently, role in the contractile
responses of the adult vasculature. To the best of our knowledge, the of role p38 MAPK in
the saphenous artery has never been studied before. We cannot exclude that p38 MAPK
regulates non-adrenergic contractions of saphenous arteries, however this is beyond the
topic of the present study.
Developmental alterations in the functional activity of different proteins regulating
smooth muscle contraction have been shown previously by our and other groups [3,5,6,26].
However, to the best of our knowledge, the developmental alteration in the functional
role of p38 MAPK has never been studied before. Our novel data suggest that, despite a
high abundance of p38 MAPK in saphenous arteries of 1- to 2-week-old rats, it does not
contribute to α1-adrenoceptor mediated contractions. Similar to the adult vasculature, the
role of p38 MAPK in non-adrenergic contractions of younger rats is possible, but needs to
be addressed in future studies.
3.2. p42/44 MAPK Regulates α1-Adrenergic Contractile Responses of Saphenous Arteries of 2- to
3-Month-Old, but Not 1- to 2-Week-Old Rats
Our data show that p42/44 MAPKs are phosphorylated and thereby activated upon
α1-adrenoceptor stimulation in saphenous arteries of adult rats. Moreover, inhibition of
p42/44 MAPK reduced α1-adrenergic contractions. These data are in accordance with
previously published data from rat aorta where contractions to an α1-adrenergic agonist
were shown to be partially mediated by p42/44 MAPK [17]. Further, a procontractile role of
p42/44 MAPK was reported for ET-1-induced contractions of rat aorta [8,11], 5HT-induced
contractions of rat carotid arteries [12,13] as well as for ANG II-induced contractions of
skeletal muscle arterioles [25].
Developmental alterations in the functional contribution of p42/44 MAPK to arterial
contraction were studied previously for ovine carotid [19] and cerebral arteries [20], but
not for muscular type arteries of the systemic circulation, such as the saphenous artery. Ac-
tivation of α1-adrenoceptors increased the phosphorylation level of p42/44 MAPK in fetal,
but not in adult, ewe middle cerebral arteries [20,21]. A higher content of p42/44 MAPK
was observed in fetal compared to adult ewe carotid arteries [19]. This was accompanied
by an elevated procontractile role of p42/44 MAPK in carotid arteries of fetal ewes [19].
In contrast to developing cerebral arteries, in the saphenous artery, i.e., a muscular
type artery of the peripheral circulation, the activation of p42/44 MAPK upon stimulation
of α1-adrenoceptors occurs predominantly in adult, but less so in 1- to 2-week-old rats
(where we observed weak phosphorylation of p44, but no phosphorylation of p42 MAPK).
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Thus, the relatively high abundance of p42/44 MAPK proteins in younger arteries does
not play a role in α1-adrenergic contractions in 1- to 2-week-old rats. Similar to p38 MAPK,
the functional contribution of p42/44 MAPK to non-adrenergic contractions of developing
arteries is the topic of future studies.
4. Materials and Methods
4.1. Animals
Experiments were performed in accordance with the European Convention on the
protection of animals used for scientific purposes (EU Directive 2010/63/EU). Animal
procedures were approved by the Biomedical Ethics Committee of the Russian Federation
State Research Center-Institute for Biomedical Problems, Russian Academy of Sciences
(protocol 426, approval date 20 June 2016). We used 10- to 15-day-old (referred as 1- to
2-week-old rats) and 2.5- to 3.5-month-old (i.e., 2- to 3-month-old rats) male Wistar rats.
Rats were sacrificed under CO2 anesthesia by decapitation. Saphenous arteries were used
as representatives for peripheral muscular type arteries.
4.2. Wire Myography
Saphenous arteries were isolated in a solution for vessel isolation (for composition
see below) and thereafter mounted in an isometric myograph (DMT, Denmark, model
610 M). The endothelium was denuded using a rat whisker. All vessels were kept at 37 ◦C
in a solution for myograph experiments (for composition see below) and bubbled with
a gas mixture (95% O2, 5% CO2). Force transducer signals were digitalized at 1 kHz and
recorded on a PC hard drive using the PowerLab 4/30 system (ADInstruments, Colorado
Springs, CO, USA) and LabChart software (ADInstruments, USA). Vessel preparations were
stretched radially to a lumen diameter corresponding to 0.9d100; where d100 is the inner
arterial diameter of relaxed arteries subjected to a transmural pressure of 100 mmHg [27].
Thereafter, preparations were activated twice with 10 µM phenylephrine and successful
endothelium removal was checked subsequently using 10 µM acetylcholine during 1–3 µM
phenylephrine-induced precontraction.
Contractile responses were studied during cumulative addition of the α1-adrenoceptor
agonist methoxamine (MX, in the concentration range from 0.01 µM to 100 µM). During
each experiment, two concentration-response relationships to MX were obtained. The
first was used to ensure comparable initial sensitivity of the vessels further treated with
either an inhibitor or its solvent. The second was used to study the effects of different
inhibitors in comparison to the application of the same volume of solvent (DMSO) or the
same concentration of an inactive inhibitor analogue. Drugs or DMSO were added 25 min
before the second MX concentration-response relationship.
Active force values were calculated by subtraction of the passive force values recorded
from the preparation with fully relaxed smooth muscle (at the beginning of each experiment
in the presence of 1 µM of the NO-donor DEA/NO). All active force values of the second
concentration-response relationship were expressed as the percentage of the maximum
active force achieved during the first concentration-response relationship. The second
concentration-response relationships are shown in the figures.
4.3. Western Blotting
For one preparation, three 2-mm segments of saphenous arteries of 2- to 3-month-old
rats, or nine 2-mm segments of saphenous arteries of 1- to 2-week-old rats, were used. The
segments were first separately mounted in a wire myograph (model 410A), normalized,
then twice activated with 10 µM phenylephrine in the same way as described above for
myograph experiments. Some preparations were twice activated with 10 µM phenyle-
phrine and 30 min later instantly frozen in liquid nitrogen (non-activated samples). Other
preparations, after activation with 10 µM phenylephrine (twice), were treated by cumula-
tive addition of MX (in the range of 0.1 µM to 10 µM) similar to concentration-response
relationships in myograph experiments. After the last concentration of MX, the vessel
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segment was instantly frozen in liquid nitrogen (activated samples). Thereafter, all samples
were homogenized in SDS-buffer (for composition see below), boiled for 5 min, centrifuged
at 12,000 rpm for 5 min and the supernatant was collected for further analysis.
Proteins were separated by SDS PAGE and transferred onto polyvinylydenedifluoride
membranes. The membranes were blocked in 5% nonfat milk in Tris-Buffered Saline
supplemented with Tween 20 (TBST, for composition see below) and sequentially incubated
with antibodies against p38 MAPK (cell signaling, 1:1000 in TBSt with 1% milk) or phospho-
p38 MAPK-Thr180/Tyr182 (cell signaling, 1:1000 in TBSt with 1% milk) or p42/44 MAPK
(cell signaling, 1:1000 in TBSt with 1% milk) or phospho-p42/44 MAPK- Thr202/Tyr204
(cell signaling, 1:1000 in TBSt with 1% milk) or GAPDH (Abcam, 1:2000 in TBSt with
1% milk). Thereafter, membranes were incubated with appropriate secondary antibodies
(antirabbit (GE Healthcare, 1:5000) or antimouse (Amersham, 1:10,000)). The protein bands
were visualized by an Enhanced Chemiluminescence (ECL) protocol using the SuperSignal
West Dura Substrate (Pierce, ThermoFisher Scientific, Waltham, MA, USA). To ensure
linearity of the chemiluminescence signal, the membranes were exposed to the film for
various time periods, then scanned using a GS-800 densitometer (Bio-Rad, Heracles, CA,
USA), and quantitatively processed with the use of the Quantity One software (Bio-Rad,
Heracles, CA, USA). Protein content was estimated by the optical density of the band,
multiplied by its area. Background intensity was determined in 3 different regions on the
film. This was used to correct the relevant bands for the background.
The data on total protein content were normalized relative to GAPDH and the average
value of the protein/GAPDH ratios in the 2- to 3-month-old group was taken as 100%. The
data on phospho-p38 MAPK and phospho-p42/44 MAPK were normalized to respective
values for total p38 MAPK and p42/44 MAPK. Considering the data on isoform-specific
roles of p42 and p44 in regulation of cellular processes [28], we estimated their phosphory-
lation levels separately. Obtained values were expressed as a percentage of the mean value
in the appropriate non-activated group.
4.4. Solutions
(1) Solution for vessel isolation, in mM: 145 NaCl, 4.5 KCl, 1.2 NaH2PO4, 1 MgSO4,
0.1 CaCl2, 0.025 EDTA and 5 HEPES.
(2) Solution for myograph experiments, in mM: 120 NaCl, 26 NaHCO3, 4.5 KCl, 1.2 NaH2PO4,
1.0 MgSO4, 1.6 CaCl2, 5.5 glucose, 0.025 EDTA and 5 HEPES; equilibrated with 5%
CO2 in 95% O2.
(3) SDS-buffer: 10% water-free glycerin, 1% SDS, 0.0625 mM tris-HCl, 5% β-mercaptoethanol
and 0.05% bromphenol blue.
(4) TBST: 20 mM tris-HCl, 20 mM NaCl, 0.1% Tween 20, pH 7.6.
4.5. Statistical Analysis
All data are presented as mean ± SEM; n represents the number of animals or the
number of samples in western blotting experiments. Statistical significance was determined
using Repeated Measures ANOVA or the unpaired Student t-test, as appropriate. Statistical
significance was reached at p < 0.05.
5. Conclusions
To conclude, our data demonstrate that, despite a high abundance of p38 and p42/44
MAPKs in peripheral muscular type arteries of rats in early postnatal ontogenesis, they
do not participate in the regulation of their contractile responses to an agonist of α1-
adrenoceptors. In this respect, peripheral arteries differ from cerebral arteries from perina-
tal animals, in which the development of contractile responses can be partially associated
with activation of p42/44 MAPKs. However, p42/44 MAPK is important for fully mani-
fested arterial contractions in adult rats. Thus, arterial functional remodeling during early
postnatal ontogenesis is not associated with a decrease in the role of p38 and p42/44
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